Curis Inc

:CRIS 4:00:00 PM EDT

1.04

-0.02 (-1.89%)

7:36:15 PM EDT: $1.10 +0.06 (+5.77%)

Market Cap (Intraday)	13.45M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$3.25 Million
Adjusted EPS	-$0.44

See more estimates

10-Day MA	$1.09
50-Day MA	$1.30
200-Day MA	$1.74

See more pivots

Curis Inc Stock, :CRIS

Building C, 128 Spring Street, Lexington, Massachusetts 02421

United States of America

Phone: +1.617.503.6500

Number of Employees: 49

http://www.curis.com

Description

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.